Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Protein-protein Interfaces02:04

Protein-protein Interfaces

15.0K
Many proteins form complexes to carry out their functions, making protein-protein interactions (PPIs) essential for an organism's survival. Most PPIs are stabilized by numerous weak noncovalent chemical forces. The physical shape of the interfaces determines the way two proteins interact. Many globular proteins have closely-matching shapes on their surfaces, which form a large number of weak bonds. Additionally, many PPIs occur between two helices or between a surface cleft and a...
15.0K
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

86
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
86
Drug Discovery: Overview01:26

Drug Discovery: Overview

13.3K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
13.3K
Pharmacodynamic Models: Additive and Proportional Drug Effect Model01:09

Pharmacodynamic Models: Additive and Proportional Drug Effect Model

67
Drug response models describe how pharmacological agents interact with biological systems to produce measurable effects. Baseline responses are inherent physiological activities without a drug significantly influencing the observed pharmacological outcomes. Depending on the drug response model employed, these baseline responses may combine with the drug's effect in either an additive or proportional manner.Additive Drug Response ModelIn the additive model, the drug effect is independent of the...
67
Protein Networks02:26

Protein Networks

4.7K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.7K
Ligand Binding Sites02:40

Ligand Binding Sites

15.8K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
15.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Public Health Messaging on Twitter During the COVID-19 Pandemic: Observational Study.

Journal of medical Internet research·2025
Same author

Weakly supervised label learning flows.

Neural networks : the official journal of the International Neural Network Society·2024
Same author

Reducing opinion polarization: Effects of exposure to similar people with differing political views.

Proceedings of the National Academy of Sciences of the United States of America·2021
Same author

Machine Learning Applications in Orthopaedic Imaging.

The Journal of the American Academy of Orthopaedic Surgeons·2020
Same author

A probabilistic approach for collective similarity-based drug-drug interaction prediction.

Bioinformatics (Oxford, England)·2016
Same author

Confident Surgical Decision Making in Temporal Lobe Epilepsy by Heterogeneous Classifier Ensembles.

Proceedings ... ICDM workshops. IEEE International Conference on Data Mining·2015

Related Experiment Video

Updated: Apr 4, 2026

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
10:21

Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

Published on: February 23, 2024

4.0K

Network-Based Drug-Target Interaction Prediction with Probabilistic Soft Logic.

Shobeir Fakhraei, Bert Huang, Louiqa Raschid

    IEEE/ACM Transactions on Computational Biology and Bioinformatics
    |September 11, 2015
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces a new computational framework for predicting drug-target interactions using probabilistic soft logic (PSL). The model leverages network structures and similarity measures to achieve state-of-the-art, interpretable predictions for drug discovery.

    More Related Videos

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.7K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.8K

    Related Experiment Videos

    Last Updated: Apr 4, 2026

    Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA
    10:21

    Author Spotlight: Streamlining Protein Target Prediction and Validation via Molecular Docking and CETSA

    Published on: February 23, 2024

    4.0K
    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
    07:40

    A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

    Published on: May 27, 2021

    4.7K
    Diagonal Method to Measure Synergy Among Any Number of Drugs
    12:08

    Diagonal Method to Measure Synergy Among Any Number of Drugs

    Published on: June 21, 2018

    19.8K

    Area of Science:

    • Computational Biology
    • Pharmacology
    • Bioinformatics

    Background:

    • Drug-target interactions are crucial for predicting therapeutic and adverse drug effects.
    • In silico prediction methods accelerate drug discovery by guiding experimental efforts.
    • Existing methods may not fully leverage network structures and diverse similarity information.

    Purpose of the Study:

    • To develop and evaluate a novel computational framework for predicting drug-target interactions.
    • To integrate drug-drug and target-target similarity measures within a unified prediction model.
    • To enhance the efficiency and interpretability of in silico drug-target interaction prediction.

    Main Methods:

    • A prediction framework based on probabilistic soft logic (PSL) was developed.
    • The model utilizes a bipartite graph of drug-target interactions, augmented with similarity measures.
    • Link prediction was optimized using blocking techniques, and models were based on triad and tetrad structures.

    Main Results:

    • The proposed PSL model achieved state-of-the-art performance in predicting drug-target interactions.
    • Rule weight learning and the use of multiple similarity measures significantly improved prediction accuracy.
    • Blocking techniques enhanced the efficiency of the link prediction process.

    Conclusions:

    • Probabilistic soft logic provides an effective and interpretable approach for drug-target interaction prediction.
    • Integrating network structures and diverse similarity measures is vital for accurate predictions.
    • The developed framework offers a valuable tool for accelerating drug discovery and development.